
UBS upgrades Jabil, citing AI, healthcare, and automation growth with a $430 price target.
UBS upgraded Jabil Inc to 'Buy' and raised its earnings estimates, driven by strong growth prospects in AI, healthcare, and automation sectors. The firm expects Jabil's AI-related revenue to grow about 50% in fiscal 2027, supported by capacity expans...
